- New Rite Aid group VP pharmacy initiatives and clinical services to oversee Wellness Ambassador program
- Shoppers Drug Mart report: Allowing pharmacists in Canada to immunize could save lives, money
- CDC: Flu vaccination prevented an estimated 6.6 million influenza-associated illnesses last season
- ROUNDTABLE: Pharmacy’s future in sync with technology
- CDC: Flu season past its peak but still going strong
CAMP HILL, Pa. — Rite Aid reported a 0.3% increase in comps for the month of January, the retail pharmacy chain said Thursday.
The increase included a 4.2% increase in front-end comps, 2.4% of which came from sales of OTC flu products. Pharmacy comps decreased by 1.4%, while same-store prescription count increased 5%, 3.4% of which came from flu-related prescriptions and flu shots. Total store sales for the four-week period, which ended Saturday, decreased 0.5% to $1.91 billion.
The retailer's January comps beat analyst estimates, particularly on the front end. Guggenheim Securities had forecast a 0.5% decrease in front-end comps, as well as a 2.5% decrease in pharmacy comps and a slightly larger decrease in overall comps.
Comps for the 47-week period that ended Saturday increased 0.1%, including a 1.6% increase in front-end comps and a 0.7% decrease in pharmacy comps as same-store prescription count increased 3.7%.
Total store sales for the 47-week period decreased 0.6% to $22.83 billion.
Find us on Facebook for even more insight, analysis and the latest in drug store news.